FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2275223613> ?p ?o ?g. }

• W2275223613 endingPage "7" @default.
• W2275223613 startingPage "15801" @default.
• W2275223613 abstract "The purpose of this study was to investigate the expression of transforming growth factor beta-activated kinase 1 (TAK1) and its activation ligand, TAK1-binding protein 1 (TAB1), in non-small cell lung carcinoma (NSCLC) and adjacent normal tissues and to analyze the relevance between TAK1 and TAB1 protein expression and the pathological features of NSCLC patients. Surgical resection NSCLC specimens were collected from 74 patients undergoing surgery in our hospital from September 2003 to July 2008; tumor-adjacent normal tissue specimens were collected as controls. All cases were pathologically confirmed after surgery, and pathological data were complete for all patients. The expression of TAK1/TAB1 proteins in NSCLC and adjacent cancer tissues was detected by immunohistochemical analysis. The correlation between TAK1/TAB1 protein expression and the clinicopathological features and outcome of NSCLC was assessed. The positive expression ratio of TAK1 in NSCLC tissue was 63.5%, which was significantly higher than that in tumor-adjacent normal tissue (31.1%). The positive expression ratio of TAB1 in NSCLC tissue was 51.4%, which was significantly higher than that in tumor-adjacent normal tissue (24.3%). Further analysis showed that positive protein expression of TAK1 and TAB1 was unrelated to patient gender, age, tumor size, degree of differentiation, and history of smoking (P>0.05) but was significantly related to clinical stage and lymph node metastasis (P<0.05). Additionally, the expression of TAK1 as well as TAB1 was negatively related to NSCLC patient prognosis, and patients with positive protein expression had a significantly lower 5-year survival rate than those with negative protein expression (P<0.05). TAK1/TAB1 expression in NSCLC tissue is significantly increased and closely associated with patient clinical prognosis. These two proteins are likely to become new therapeutic targets for the treatment of NSCLC." @default.
• W2275223613 created "2016-06-24" @default.
• W2275223613 creator A5012737536 @default.
• W2275223613 creator A5031291553 @default.
• W2275223613 creator A5054651477 @default.
• W2275223613 creator A5062388901 @default.
• W2275223613 date "2015-01-01" @default.
• W2275223613 modified "2023-09-23" @default.
• W2275223613 title "Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance." @default.
• W2275223613 cites W1974213646 @default.
• W2275223613 cites W1979328434 @default.
• W2275223613 cites W1999207367 @default.
• W2275223613 cites W2008955645 @default.
• W2275223613 cites W2023898364 @default.
• W2275223613 cites W2037385288 @default.
• W2275223613 cites W2059421466 @default.
• W2275223613 cites W2075446507 @default.
• W2275223613 cites W2086722326 @default.
• W2275223613 cites W2150670229 @default.
• W2275223613 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4730063" @default.
• W2275223613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26884850" @default.
• W2275223613 hasPublicationYear "2015" @default.
• W2275223613 type Work @default.
• W2275223613 sameAs 2275223613 @default.
• W2275223613 citedByCount "4" @default.
• W2275223613 countsByYear W22752236132017 @default.
• W2275223613 countsByYear W22752236132018 @default.
• W2275223613 countsByYear W22752236132022 @default.
• W2275223613 crossrefType "journal-article" @default.
• W2275223613 hasAuthorship W2275223613A5012737536 @default.
• W2275223613 hasAuthorship W2275223613A5031291553 @default.
• W2275223613 hasAuthorship W2275223613A5054651477 @default.
• W2275223613 hasAuthorship W2275223613A5062388901 @default.
• W2275223613 hasConcept C126322002 @default.
• W2275223613 hasConcept C142724271 @default.
• W2275223613 hasConcept C146357865 @default.
• W2275223613 hasConcept C151730666 @default.
• W2275223613 hasConcept C204232928 @default.
• W2275223613 hasConcept C207886595 @default.
• W2275223613 hasConcept C2776256026 @default.
• W2275223613 hasConcept C2777546739 @default.
• W2275223613 hasConcept C63363279 @default.
• W2275223613 hasConcept C71924100 @default.
• W2275223613 hasConcept C86803240 @default.
• W2275223613 hasConceptScore W2275223613C126322002 @default.
• W2275223613 hasConceptScore W2275223613C142724271 @default.
• W2275223613 hasConceptScore W2275223613C146357865 @default.
• W2275223613 hasConceptScore W2275223613C151730666 @default.
• W2275223613 hasConceptScore W2275223613C204232928 @default.
• W2275223613 hasConceptScore W2275223613C207886595 @default.
• W2275223613 hasConceptScore W2275223613C2776256026 @default.
• W2275223613 hasConceptScore W2275223613C2777546739 @default.
• W2275223613 hasConceptScore W2275223613C63363279 @default.
• W2275223613 hasConceptScore W2275223613C71924100 @default.
• W2275223613 hasConceptScore W2275223613C86803240 @default.
• W2275223613 hasIssue "12" @default.
• W2275223613 hasLocation W22752236131 @default.
• W2275223613 hasOpenAccess W2275223613 @default.
• W2275223613 hasPrimaryLocation W22752236131 @default.
• W2275223613 hasRelatedWork W1577472668 @default.
• W2275223613 hasRelatedWork W1964933292 @default.
• W2275223613 hasRelatedWork W2092931831 @default.
• W2275223613 hasRelatedWork W2347778667 @default.
• W2275223613 hasRelatedWork W2347956231 @default.
• W2275223613 hasRelatedWork W2360428741 @default.
• W2275223613 hasRelatedWork W2366827179 @default.
• W2275223613 hasRelatedWork W2368027314 @default.
• W2275223613 hasRelatedWork W2463033561 @default.
• W2275223613 hasRelatedWork W3029310622 @default.
• W2275223613 hasVolume "8" @default.
• W2275223613 isParatext "false" @default.
• W2275223613 isRetracted "false" @default.
• W2275223613 magId "2275223613" @default.
• W2275223613 workType "article" @default.